These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8720208)

  • 1. Stability: an ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia.
    Higgins SL; Lee RS; Kramer RL
    J Cardiovasc Electrophysiol; 1995 Dec; 6(12):1081-8. PubMed ID: 8720208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
    Swerdlow CD; Chen PS; Kass RM; Allard JR; Peter CT
    J Am Coll Cardiol; 1994 May; 23(6):1342-55. PubMed ID: 8176092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimized programming of sustained rate duration in patients with implantable cardioverter-defibrillators and diagnosed atrial fibrillation].
    Wieckhorst A; Buchwald AB; Unterberg C
    Z Kardiol; 1999 Jun; 88(6):426-33. PubMed ID: 10441813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy.
    Neuzner J; Pitschner HF; Schlepper M
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 2):539-47. PubMed ID: 7777418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates.
    Kettering K; Dörnberger V; Lang R; Vonthein R; Suchalla R; Bosch RF; Mewis C; Eigenberger B; Kühlkamp V
    Pacing Clin Electrophysiol; 2001 Sep; 24(9 Pt 1):1325-33. PubMed ID: 11584454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing.
    Kühlkamp V; Dörnberger V; Mewis C; Suchalla R; Bosch RF; Seipel L
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):905-15. PubMed ID: 10413370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators.
    Weber M; Böcker D; Bänsch D; Brunn J; Castrucci M; Gradaus R; Breithardt G; Block M
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):145-53. PubMed ID: 10090217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.
    Hurwitz JL; Hook BG; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Mar; 21(4):895-900. PubMed ID: 8450157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation.
    García-Alberola A; Yli-Mäyry S; Block M; Haverkamp W; Martínez-Rubio A; Kottkamp H; Breithardt G; Borggrefe M
    Circulation; 1996 Jan; 93(2):295-300. PubMed ID: 8548902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Participating Centers of the Automatic Recognition of Arrhythmia Study Group.
    Nair M; Saoudi N; Kroiss D; Letac B
    Circulation; 1997 Feb; 95(4):967-73. PubMed ID: 9054759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia.
    Kouakam C; Kacet S; Hazard JR; Ferraci A; Mansour H; Defaye P; Davy JM; Lambiez M;
    Europace; 2004 Jan; 6(1):32-42. PubMed ID: 14697724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of basic ventricular tachycardia detection algorithms in implantable cardioverter defibrillators: implications for device programming.
    Anderson MH; Murgatroyd FD; Hnatkova K; Xie B; Jones S; Rowland E; Ward DE; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2975-83. PubMed ID: 9455760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced detection criteria in implantable defibrillators.
    Brugada J; Mont L; Figueiredo M; Valentino M; Matas M; Navarro-López F
    J Cardiovasc Electrophysiol; 1998 Mar; 9(3):261-8. PubMed ID: 9554731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.